Literature DB >> 35066661

Pipeline flow diversion with adjunctive coil embolization for internal carotid artery aneurysms following an intradural component: results in 46 consecutive aneurysms from a Japanese single-center experience.

Tomoaki Akiyama1, Hirotoshi Imamura2, Masanori Goto2, Ryu Fukumitsu2, Tadashi Sunohara2, Shirabe Matsumoto2, Nobuyuki Fukui2, Yoshihiro Omura2, Tatsumaru Fukuda2, Koichi Go2, Shinji Kajiura2, Masashi Shigeyasu2, Kento Asakura2, Ryo Horii2, Yuji Naramoto2, Rikuo Nishii2, Yasuhiro Yamamoto2, Chiaki Sakai2, Nobuyuki Sakai2.   

Abstract

In the treatment of an intracranial aneurysm with the flow diverter, the combined use of coil embolization can help promote subsequent progressive thrombosis within the aneurysm sac and reduce the risk of delayed aneurysm rupture. This study retrospectively reviewed outcomes of patients who had undergone the Pipeline Embolization Device (PED) with adjunctive coil embolization (PED/coil) at a single center to determine its safety and efficiency. Patients with internal carotid artery aneurysms following an intradural component were selected for PED/coil between 2015 and 2020. All patients were premedicated with dual antiplatelet therapy of aspirin plus clopidogrel or prasugrel. A minimal number of PEDs were deployed, with coils inserted using a stent-jail technique, avoiding dense packing. A total of 46 aneurysms (43 patients; median dome size, 11.6 mm; median neck width, 6.3 mm) were treated with PED/coil. The median volume embolization ratio was 14.8%. The degree of angiographic filling at the 6-month and latest angiography showed complete occlusion in 60.5% (26/43) and 70.5% (31/44), respectively. Small (< 10 mm) aneurysms achieved a higher complete occlusion rate in the early period; a lower cumulative incidence of aneurysm occlusion was observed in large and giant (≥ 10 mm) aneurysms (P = .024). The median clinical follow-up was 22 months, and no aneurysm ruptures occurred. Favorable clinical outcomes were achieved, with permanent neurological morbidity of 4.7% and no mortality. PED/coil demonstrated a high angiographic occlusion rate at an early stage. Loosely packed coils are sufficient to obliterate aneurysms effectively.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Adjunctive coil embolization; Delayed aneurysm rupture; Flow diverter; Intracranial aneurysm; Pipeline Embolization Device

Year:  2022        PMID: 35066661     DOI: 10.1007/s10143-021-01719-7

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  27 in total

1.  Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment.

Authors:  Z Kulcsár; E Houdart; A Bonafé; G Parker; J Millar; A J P Goddard; S Renowden; G Gál; B Turowski; K Mitchell; F Gray; M Rodriguez; R van den Berg; A Gruber; H Desal; I Wanke; D A Rüfenacht
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-11       Impact factor: 3.825

2.  Safety and efficacy of the Pipeline embolization device for treatment of intracranial aneurysms: a pooled analysis of 3 large studies.

Authors:  David F Kallmes; Waleed Brinjikji; Saruhan Cekirge; David Fiorella; Ricardo A Hanel; Pascal Jabbour; Demetrius Lopes; Pedro Lylyk; Cameron G McDougall; Adnan Siddiqui
Journal:  J Neurosurg       Date:  2016-10-28       Impact factor: 5.115

3.  Periprocedural complications of second-generation flow diverter treatment using Pipeline Flex for unruptured intracranial aneurysms: a systematic review and meta-analysis.

Authors:  Kartik Dev Bhatia; Hans Kortman; Emanuele Orru; Jesse M Klostranec; Vitor M Pereira; Timo Krings
Journal:  J Neurointerv Surg       Date:  2019-05-30       Impact factor: 5.836

4.  Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial.

Authors:  Tibor Becske; David F Kallmes; Isil Saatci; Cameron G McDougall; István Szikora; Giuseppe Lanzino; Christopher J Moran; Henry H Woo; Demetrius K Lopes; Aaron L Berez; Daniel J Cher; Adnan H Siddiqui; Elad I Levy; Felipe C Albuquerque; David J Fiorella; Zsolt Berentei; Miklós Marosfoi; Saruhan H Cekirge; Peter K Nelson
Journal:  Radiology       Date:  2013-02-15       Impact factor: 11.105

5.  International retrospective study of the pipeline embolization device: a multicenter aneurysm treatment study.

Authors:  D F Kallmes; R Hanel; D Lopes; E Boccardi; A Bonafé; S Cekirge; D Fiorella; P Jabbour; E Levy; C McDougall; A Siddiqui; I Szikora; H Woo; F Albuquerque; H Bozorgchami; S R Dashti; J E Delgado Almandoz; M E Kelly; R Turner; B K Woodward; W Brinjikji; G Lanzino; P Lylyk
Journal:  AJNR Am J Neuroradiol       Date:  2014-10-29       Impact factor: 3.825

Review 6.  Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis.

Authors:  Waleed Brinjikji; Mohammad H Murad; Giuseppe Lanzino; Harry J Cloft; David F Kallmes
Journal:  Stroke       Date:  2013-01-15       Impact factor: 7.914

7.  Neuroform stent-assisted coil embolization of wide-neck intracranial aneurysms: strategies in stent deployment and midterm follow-up.

Authors:  Alessandra Biondi; Vallabh Janardhan; Jeffrey M Katz; Kimberly Salvaggio; Howard A Riina; Y Pierre Gobin
Journal:  Neurosurgery       Date:  2007-09       Impact factor: 4.654

8.  A new endoluminal, flow-disrupting device for treatment of saccular aneurysms.

Authors:  David F Kallmes; Yong Hong Ding; Daying Dai; Ramanathan Kadirvel; Debra A Lewis; Harry J Cloft
Journal:  Stroke       Date:  2007-07-05       Impact factor: 7.914

Review 9.  Delayed hemorrhagic complications after flow diversion for intracranial aneurysms: a literature overview.

Authors:  Aymeric Rouchaud; Waleed Brinjikji; Giuseppe Lanzino; Harry J Cloft; Ramanathan Kadirvel; David F Kallmes
Journal:  Neuroradiology       Date:  2015-11-09       Impact factor: 2.804

10.  Prospective study on embolization of intracranial aneurysms with the pipeline device: the PREMIER study 1 year results.

Authors:  Ricardo A Hanel; David F Kallmes; Demetrius Klee Lopes; Peter Kim Nelson; Adnan Siddiqui; Pascal Jabbour; Vitor M Pereira; Istvan Szikora István; Osama O Zaidat; Chetan Bettegowda; Geoffrey P Colby; Maxim Mokin; Clemens Schirmer; Frank R Hellinger; Curtis Given Ii; Timo Krings; Philipp Taussky; Gabor Toth; Justin F Fraser; Michael Chen; Ryan Priest; Peter Kan; David Fiorella; Don Frei; Beverly Aagaard-Kienitz; Orlando Diaz; Adel M Malek; C Michael Cawley; Ajit S Puri
Journal:  J Neurointerv Surg       Date:  2019-07-15       Impact factor: 5.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.